Clinical Trials Logo

Clinical Trial Summary

The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.


Clinical Trial Description

This is a phase IV, multi-center, single-arm, observational study evaluating the outcomes of native coronary artery PCI in patients presenting with severe SVG lesions. Subjects will undergo clinically-indicated PCI of the native coronary artery that supplies the territory subtended by the diseased SVG at the discretion of the treating physicians. The study team will screen and enroll patients after completion of index procedure. ;


Study Design


NCT number NCT05187351
Study type Observational
Source Minneapolis Heart Institute Foundation
Contact Emmanouil Brilakis, MD, PhD
Phone 612-863-3852
Email [email protected]
Status Recruiting
Phase
Start date November 21, 2021
Completion date January 2030